287 related articles for article (PubMed ID: 19167523)
21. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
22. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.
James JA; Neas BR; Moser KL; Hall T; Bruner GR; Sestak AL; Harley JB
Arthritis Rheum; 2001 May; 44(5):1122-6. PubMed ID: 11352244
[TBL] [Abstract][Full Text] [Related]
23. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
Front Immunol; 2022; 13():830993. PubMed ID: 35251022
[TBL] [Abstract][Full Text] [Related]
24. EBV and systemic lupus erythematosus: a new perspective.
Gross AJ; Hochberg D; Rand WM; Thorley-Lawson DA
J Immunol; 2005 Jun; 174(11):6599-607. PubMed ID: 15905498
[TBL] [Abstract][Full Text] [Related]
25. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
Jog NR; Young KA; Munroe ME; Harmon MT; Guthridge JM; Kelly JA; Kamen DL; Gilkeson GS; Weisman MH; Karp DR; Gaffney PM; Harley JB; Wallace DJ; Norris JM; James JA
Ann Rheum Dis; 2019 Sep; 78(9):1235-1241. PubMed ID: 31217170
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus.
Poole BD; Scofield RH; Harley JB; James JA
Autoimmunity; 2006 Feb; 39(1):63-70. PubMed ID: 16455583
[TBL] [Abstract][Full Text] [Related]
27. [Systemic lupus erythematosus and Epstein-Barr virus].
Tazi I; Fehri S; Elghrari K; Ouazzani T; Benchemsi N
East Mediterr Health J; 2009; 15(3):701-8. PubMed ID: 19731786
[TBL] [Abstract][Full Text] [Related]
28. The curiously suspicious: a role for Epstein-Barr virus in lupus.
Harley JB; Harley IT; Guthridge JM; James JA
Lupus; 2006; 15(11):768-77. PubMed ID: 17153849
[TBL] [Abstract][Full Text] [Related]
29. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
30. Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study.
Esen BA; Yılmaz G; Uzun S; Ozdamar M; Aksözek A; Kamalı S; Türkoğlu S; Gül A; Ocal L; Aral O; Inanç M
Rheumatol Int; 2012 Jan; 32(1):79-83. PubMed ID: 20661740
[TBL] [Abstract][Full Text] [Related]
31. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
[TBL] [Abstract][Full Text] [Related]
32. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease.
Zandman-Goddard G; Berkun Y; Barzilai O; Boaz M; Blank M; Ram M; Sherer Y; Anaya JM; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():658-63. PubMed ID: 19758212
[TBL] [Abstract][Full Text] [Related]
33. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
Csorba K; Schirmbeck LA; Tuncer E; Ribi C; Roux-Lombard P; Chizzolini C; Huynh-Do U; Vanhecke D; Trendelenburg M
Front Immunol; 2019; 10():2619. PubMed ID: 31787984
[TBL] [Abstract][Full Text] [Related]
34. Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.
Sternbæk L; Draborg AH; Østerlund MT; Iversen LV; Troelsen L; Theander E; Nielsen CT; Jacobsen S; Houen G
Scand J Clin Lab Invest; 2019; 79(1-2):7-16. PubMed ID: 30727744
[TBL] [Abstract][Full Text] [Related]
35. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
37. Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus.
Huggins ML; Todd I; Powell RJ
Rheumatol Int; 2005 Apr; 25(3):183-7. PubMed ID: 14666378
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.
França SAS; Viana JBGO; Góes HCA; Fonseca RRS; Laurentino RV; Costa IB; Oliveira-Filho AB; Machado LFA
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458425
[TBL] [Abstract][Full Text] [Related]
39. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.
Jog NR; James JA
Front Immunol; 2020; 11():623944. PubMed ID: 33613559
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus in autoimmune diseases.
Toussirot E; Roudier J
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):883-96. PubMed ID: 19028369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
